|

AMICUS THERAPEUTICS INC (FOLD)

US03152W1099 - Common Stock

11.45  +0.23 (+2.05%)

After market: 11.48 +0.03 (+0.26%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-9-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
372.40M329.20M305.50M260.90M182.20M
Cost Of Goods
35.30M38.60M34.50M31.00M22.00M
Gross Profit
337.00M290.60M271.00M229.80M160.30M
Operating Expenses
451.80M496.20M477.40M476.90M464.30M
Research and Development
181.20M276.70M272.00M308.40M286.40M
Selling, General, and Administrative Expenses
259.40M213.00M192.70M156.40M169.90M
Operating Income
-114.70M-205.50M-206.40M-247.00M-304.10M
Interest Income/Expense
-41.10M-34.10M-32.00M-19.20M-8.60M
Other Income/Expense
-31.60M4.20M-2.90M-800.00K-2.60M
Non Recurring Items
-1.10M-6.60M-300.00K-7.30M-40.60M
Income Before Taxes
-188.50M-242.00M-241.60M-274.30M-355.90M
Income Tax
-14.90M-5.50M8.90M2.60M500.00K
Net Income
-173.60M-236.60M-250.50M-276.90M-356.40M
EBITDA
-107.70M-200.16M-200.19M-238.15M-299.32M
 
Per Share Data
EPS Diluted Total Ops
-0.59-0.82-0.92-1.07-1.48
Non GAAP EPS
-0.59-0.82-0.92-1.04-1.34
 
Statistics
Gross Profit Margin
90.49%88.27%88.71%88.08%87.98%
Profit Margin
-46.62%-71.87%-82.00%-106.13%-195.61%
Operating Profit Margin
-30.80%-62.42%-67.56%-94.67%-166.90%

All data in USD

Charts